Yahoo Suche Web Suche

Suchergebnisse

  1. Suchergebnisse:
  1. Our mission at Spark Therapeutics is to unlock the power of gene therapy to accelerate healthcare transformation. We have built a fully integrated company, combining our proprietary adeno-associated viral (AAV) gene therapy platform with excellence in R&D, manufacturing and commercial operations.

  2. www.roche.com › innovation › structureRoche | Spark

    Spark Therapeutics was founded in 2013 and became a Member of the Roche Group in 2019. The organisation is a fully integrated, commercial company committed to discovering, developing and delivering gene therapies for genetic diseases, including inherited retinal disorders, haemophilia, lysosomal storage disorders and neurodegenerative diseases.

  3. The company is currently developing several gene therapies to target a suite of diseases, including Haemophilia A and B, and several central nervous system diseases. In December 2019, the company was acquired by Hoffmann-La Roche for $4.3 billion. [6] [7] It now continues to operate as an independent subsidiary. [8]

  4. 23. Feb. 2022 · Spark Therapeutics is a fully integrated, commercial company committed to discovering, developing and delivering gene therapies. Founded in 2013, Spark Therapeutics is the first company in the U.S. to receive FDA approval of a gene therapy for a genetic disease.

  5. Spark Therapeutics, Inc. | 87,207 followers on LinkedIn. Our mission is to unlock the power of gene therapy to accelerate healthcare transformation. | At Spark® Therapeutics, we believe in...

  6. 17. Dez. 2019 · Spark Therapeutics is a fully integrated, commercial company committed to discovering, developing and delivering gene therapies. The company challenges the inevitability of genetic diseases,...